Search results
Results from the WOW.Com Content Network
The revised Five-factor score is associated with 5-year mortality from GPA and is based on the following criteria: age greater than 65 years, cardiac symptoms, gastrointestinal involvement, chronic kidney disease, and the absence of ears, nose, and throat symptoms. [7] With corticosteroids and cyclophosphamide, 5-year survival is over 80%. [13]
Granulomatous–lymphocytic interstitial lung disease (GLILD) is a lung complication of common variable immunodeficiency disorders (CVID). It is seen in approximately 15% of patients with CVID. [ 1 ] It has been defined histologically as the presence of (non-caseating) granuloma and lymphoproliferation in the lung. [ 1 ]
Granuloma; Picture of a granuloma (without necrosis) as seen through a microscope on a glass slide: The tissue on the slide is stained with two standard dyes (hematoxylin: blue, eosin: pink) to make it visible. The granuloma in this picture was found in a lymph node of a patient with a Mycobacterium avium infection. Specialty: Pathology
Chronic granulomatous disease (CGD), also known as Bridges–Good syndrome, chronic granulomatous disorder, and Quie syndrome, [1] is a diverse group of hereditary diseases in which certain cells of the immune system have difficulty forming the reactive oxygen compounds (most importantly the superoxide radical due to defective phagocyte NADPH oxidase) used to kill certain ingested pathogens. [2]
Eosinophilic granulomatosis with polyangiitis consists of three stages, but not all patients develop all three stages or progress from one stage to the next in the same order; [7] whereas some patients may develop severe or life-threatening complications such as gastrointestinal involvement and heart disease, some patients are only mildly affected, e.g. with skin lesions and nasal polyps. [8]
Over the past 20 years — between 2000 and 2019; the study doesn’t include data from 2020 through the present — the average lifespan worldwide has extended by 6.5 years.
Even with treatment, only around 20% of people survive five years on from their diagnosis. [4] Survival rates are higher in those diagnosed at an earlier stage, diagnosed at a younger age, and in women compared to men. Most lung cancer cases are caused by tobacco smoking.
Meet the experts: Thomas Russo, M.D., professor and chief of infectious disease at the University at Buffalo in New York; infectious disease expert Amesh A. Adalja, M.D., senior scholar at the ...